ROZANOLIXIZUMAB — all Canadian products
4 DINs
4 marketed/approved
0 in shortage
Every Health Canada Drug Identification Number whose active ingredient is ROZANOLIXIZUMAB, with holder, form, strength and current status, compared weekly against the Drug Product Database.
| DIN | Product | Company | Form | Route | Strength | Status | Shortage |
|---|---|---|---|---|---|---|---|
| 02556081 | RYSTIGGO | UCB CANADA INC | Solution | Subcutaneous | ROZANOLIXIZUMAB 280 MG | Marketed | |
| 02567067 | RYSTIGGO | UCB CANADA INC | Solution | Subcutaneous | ROZANOLIXIZUMAB 420 MG | Approved | |
| 02567075 | RYSTIGGO | UCB CANADA INC | Solution | Subcutaneous | ROZANOLIXIZUMAB 560 MG | Approved | |
| 02567083 | RYSTIGGO | UCB CANADA INC | Solution | Subcutaneous | ROZANOLIXIZUMAB 840 MG | Approved |
Browse other molecules: